Ambulatory blood pressure and arterial stiffness web-based telemonitoring in patients at cardiovascular risk. First results of the VASOTENS (Vascular health ASsessment Of The hypertENSive patients) Registry

Autor: Omboni S., Posokhov I., Parati G., Rogoza A., Kotovskaya Y., Arystan A., Avolio A., Barkan V., Bulanova N., Cardona Munoz E., Grigoricheva E., Konradi A., Minyukhina I., Muiesan M. L., Mule G., Orlova I., Pereira T., Peixoto Maldonado J. M., Statsenko M. E., Tilea I., Waisman G., Forcada P., Zelveian P., Butlin M., Barin E., Tan I., Ghiadoni L., Bruno R. M., Sarzani R., Espinosa E., Volpe M., Savoia C., Tocci G., Borghi C., Schillaci G., Pucci G., Paini A., Rizzoni D., Ramos C., Alanis A., Varga A., Volkov D., Kurlykina N., Rotar O., Orlov A., Gorbunov V., Boytsov S., Fedorova E., Korneva V., Kuznetsova T., Kulikova N., Evdokimov V. V., Kuznetsova A., Zheleznyak E., Kobalava Z., Borisova I., Svetozarsky T., Gubanova M., Lazareva V., Derevyanchenko M. V., Kopylov P., Sirenko Y., Recovets O., Borghi C

Publikováno v: J Clin Hypertens (Greenwich)

The VASOTENS Registry is an international telehealth-based repository of 24-hour ambulatory blood pressure monitorings (ABPM) obtained through an oscillometric upper-arm BP monitor allowing combined estimation of some vascular biomarkers. The present

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef195c68d6716efe24b19cdfcb009ba
http://hdl.handle.net/11573/1303553

BTG1 mutation yields supercompetitive B cells primed for malignant transformation.

Autor: Mlynarczyk C; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Teater M; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Pae J; Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA., Chin CR; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Tri-Institutional PhD Program in Computational Biomedicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Wang L; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Arulraj T; Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany., Barisic D; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Papin A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Hoehn KB; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Kots E; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA., Ersching J; Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA., Bandyopadhyay A; Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany., Barin E; Department of Pharmacology and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Poh HX; Department of Pharmacology and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Evans CM; Molecular Pharmacology Program and Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA., Chadburn A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Chen Z; Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Shen H; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Isles HM; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Pelzer B; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Tsialta I; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Doane AS; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA., Geng H; Department of Laboratory Medicine, University of California, San Francisco, CA, USA., Rehman MH; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Weill Cornell Medicine-Qatar, Doha, Qatar., Melnick J; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Morgan W; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Nguyen DTT; Molecular Pharmacology Program and Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Elemento O; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine and Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA., Kharas MG; Molecular Pharmacology Program and Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jaffrey SR; Department of Pharmacology and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Khelashvili G; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA., Meyer-Hermann M; Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany.; Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität Braunschweig, Braunschweig, Germany., Victora GD; Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA., Melnick A; Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2023 Jan 20; Vol. 379 (6629), pp. eabj7412. Date of Electronic Publication: 2023 Jan 20.

N ⁶ -Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.

Autor: Cheng Y; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xie W; Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Pickering BF; Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY, USA., Chu KL; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA., Savino AM; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yang X; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Luo H; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nguyen DT; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mo S; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Barin E; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Velleca A; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rohwetter TM; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Patel DJ; Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Jaffrey SR; Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, NY, USA., Kharas MG; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: kharasm@mskcc.org.

Publikováno v: Cancer cell [Cancer Cell] 2021 Jul 12; Vol. 39 (7), pp. 958-972.e8. Date of Electronic Publication: 2021 May 27.

085 “Batting above the Average”- 2 Year Follow-up of an Early Review Clinic for Heart Failure Patients that has Sustained Reduced Readmissions and Improved Patient Outcomes

Autor: Rao, A., Hales, S., Mou, D., Kanagaratnam, L., Barin, E., Gan, G., Sindone, A.

Publikováno v: In Heart, Lung and Circulation 2020 29 Supplement 2:S75-S75

Systemic alterations play a dominant role in epigenetic predisposition to breast cancer in offspring of obese fathers and is transmitted to a second generation.

Autor: Fontelles CC; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, The Research Building, Room E410, Washington, DC, 20057, USA., da Cruz RS; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, The Research Building, Room E410, Washington, DC, 20057, USA., Gonsiewski AK; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, The Research Building, Room E410, Washington, DC, 20057, USA., Barin E; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, The Research Building, Room E410, Washington, DC, 20057, USA., Tekmen V; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, The Research Building, Room E410, Washington, DC, 20057, USA., Jin L; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, The Research Building, Room E410, Washington, DC, 20057, USA., Cruz MI; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, The Research Building, Room E410, Washington, DC, 20057, USA., Loudig O; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, The Research Building, Room E410, Washington, DC, 20057, USA.; Center for Discovery and Innovation, Hackensack Meridian Health (HMH), Nutley, NJ, USA., Warri A; Institute of Biomedicine, University of Turku Medical Faculty, 20014, Turku, Finland. awarri@utu.fi., de Assis S; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road, NW, The Research Building, Room E410, Washington, DC, 20057, USA. deassiss@georgetown.edu.

Publikováno v: Scientific reports [Sci Rep] 2021 Apr 01; Vol. 11 (1), pp. 7317. Date of Electronic Publication: 2021 Apr 01.